HELP

FEEDBACK

SUBSCRIPTIONS

ARCHIVE

TABLE OF CONTENTS

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):
Year:		Vol:		Page:

	Help viewing high resolution images
	Return to article

Click on image to view larger version.

FIGURE 3. Tumor pretargeting with bispecific construct. Bispecific agent (e.g., bispecific antibody or antibody/streptavidin fusion) is administered and saturates antigenic sites on tumor. Subsequently, a small radionuclide carrier is administered and binds to the tumor-localizing bispecific agent.

Return to article